GB2593874A - Portable brain scanner - Google Patents
Portable brain scanner Download PDFInfo
- Publication number
- GB2593874A GB2593874A GB2004587.8A GB202004587A GB2593874A GB 2593874 A GB2593874 A GB 2593874A GB 202004587 A GB202004587 A GB 202004587A GB 2593874 A GB2593874 A GB 2593874A
- Authority
- GB
- United Kingdom
- Prior art keywords
- spect
- eeg
- neuroimaging
- brain
- scanner
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004556 brain Anatomy 0.000 title description 43
- 238000002603 single-photon emission computed tomography Methods 0.000 claims abstract description 39
- 238000002610 neuroimaging Methods 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims description 17
- 238000012545 processing Methods 0.000 claims description 13
- 230000010354 integration Effects 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 4
- 235000004240 Triticum spelta Nutrition 0.000 claims description 3
- 238000000537 electroencephalography Methods 0.000 abstract description 34
- 230000005856 abnormality Effects 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 description 16
- 238000003745 diagnosis Methods 0.000 description 16
- 208000029028 brain injury Diseases 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 230000005855 radiation Effects 0.000 description 7
- 239000012217 radiopharmaceutical Substances 0.000 description 7
- 229940121896 radiopharmaceutical Drugs 0.000 description 7
- 230000002799 radiopharmaceutical effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 238000002595 magnetic resonance imaging Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 238000002600 positron emission tomography Methods 0.000 description 5
- 229910021607 Silver chloride Inorganic materials 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000006931 brain damage Effects 0.000 description 4
- 231100000874 brain damage Toxicity 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
- 208000003174 Brain Neoplasms Diseases 0.000 description 3
- 238000004497 NIR spectroscopy Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 108010038447 Chromogranin A Proteins 0.000 description 2
- 102100031186 Chromogranin-A Human genes 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010019196 Head injury Diseases 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- FHNFHKCVQCLJFQ-NJFSPNSNSA-N Xenon-133 Chemical compound [133Xe] FHNFHKCVQCLJFQ-NJFSPNSNSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052790 beryllium Inorganic materials 0.000 description 2
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-YPZZEJLDSA-N iodine-125 Chemical compound [125I] ZCYVEMRRCGMTRW-YPZZEJLDSA-N 0.000 description 2
- 229940044173 iodine-125 Drugs 0.000 description 2
- CPTIBDHUFVHUJK-NZYDNVMFSA-N mitopodozide Chemical compound C1([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H](CO)[C@@H]2C(=O)NNCC)=CC(OC)=C(OC)C(OC)=C1 CPTIBDHUFVHUJK-NZYDNVMFSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 229910052713 technetium Inorganic materials 0.000 description 2
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- 229940106670 xenon-133 Drugs 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 238000012351 Integrated analysis Methods 0.000 description 1
- ZCYVEMRRCGMTRW-AHCXROLUSA-N Iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- YCKRFDGAMUMZLT-BJUDXGSMSA-N fluorine-18 atom Chemical compound [18F] YCKRFDGAMUMZLT-BJUDXGSMSA-N 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000012880 independent component analysis Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000009126 molecular therapy Methods 0.000 description 1
- 238000000491 multivariate analysis Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 206010041569 spinal fracture Diseases 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- BKVIYDNLLOSFOA-OIOBTWANSA-N thallium-201 Chemical compound [201Tl] BKVIYDNLLOSFOA-OIOBTWANSA-N 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000007473 univariate analysis Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
- A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/251—Means for maintaining electrode contact with the body
- A61B5/256—Wearable electrodes, e.g. having straps or bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/384—Recording apparatus or displays specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6803—Head-worn items, e.g. helmets, masks, headphones or goggles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/7425—Displaying combinations of multiple images regardless of image source, e.g. displaying a reference anatomical image with a live image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/06—Diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
- A61B6/4258—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4275—Arrangements for detecting radiation specially adapted for radiation diagnosis using a detector unit almost surrounding the patient, e.g. more than 180°
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/44—Constructional features of apparatus for radiation diagnosis
- A61B6/4405—Constructional features of apparatus for radiation diagnosis the apparatus being movable or portable, e.g. handheld or mounted on a trolley
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/44—Constructional features of apparatus for radiation diagnosis
- A61B6/4417—Constructional features of apparatus for radiation diagnosis related to combined acquisition of different diagnostic modalities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
- A61B6/5247—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image combining images from an ionising-radiation diagnostic technique and a non-ionising radiation diagnostic technique, e.g. X-ray and ultrasound
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/16—Measuring radiation intensity
- G01T1/1603—Measuring radiation intensity with a combination of at least two different types of detector
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F5/00—Transportable or portable shielded containers
- G21F5/015—Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
- A61B6/4225—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using image intensifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/44—Constructional features of apparatus for radiation diagnosis
- A61B6/4411—Constructional features of apparatus for radiation diagnosis the apparatus being modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
- A61B6/5235—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image combining images from the same or different ionising radiation imaging techniques, e.g. PET and CT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Optics & Photonics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Psychiatry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A neuroimaging system comprises an electroencephalography (EEG) and a single-photon emission computed tomography (SPECT) device, which are simultaneously used on a patient. Scan outputs from both EEG and SPECT are processed and displayed to the user, with e.g. EEG packets linked to software analysing gamma camera images. The SPECT device may comprise a collimator, scintillator and gamma camera. A power regulator may feed power to the EEG and SPECT devices at different levels. The neuroimaging system may be portable, i.e. not fixed in a single location and can be moved with minimal set-up. This may allow determination of both functional and structural abnormalities, in a scanner used out of hospital, bringing neuroimaging near to the patient for early intervention.
Description
Portable Brain Scanner [001] The present invention relates to a portable brain scanner. Specifically, the invention relates to a portable brain scanner combining two methods of neuroimaging. I ven more specifically the invention relates to a portable brain scanner combining electroencephalography (EEG) and single-photon emission computed tomography (SPI
Background of the Invention
[002] NeuroimagMg has been an area given keen attention from many researchers. It is an important area of study. So far, the brain is one of if not the most vital organ of the body, and hence, it's imaging as port of the diagnosis is important. In the 211 century, many developments have been made, and sophisticated equipment for neuroim agthg have been developed. Some old methods, such as Computerized Tomography (CT) have been improved. X-rays and Magnetic resonance imaging (MR1) machines have been created and modulated to give precise images. However, most of these machines are not portable due to their size.
[003] Neuroimaging is an essential medical imaging technique that is extensively used in a various preclinical and clinical settings. Structural imaging enables diagnosis of large-scale neural diseases such as tumours, neurodegenerative diseases, and brain injury. Functional imaging, on the other hand, aids in diagnosing metabolic abnormalities and lesions that interfere with cognition and the functions of the brain. The technologies involved and the equipment are quite expensive, and they are brought by just a few people or well-established hospitals. Though the advancements aid in the mitigation of life-threatening neural events, they are largely unavailable to the public for utilization. For instance, Magnetic resonance Imaging (MR1) besides costing millions of dollars, is bulky and cannot be moved from its point of installation, hence its disadvantage to be used in an out of hospital setting where dose monitoring of pharmaceuticals, the effectiveness of therapy and assessment of brain damage can be done.
[0041 In the recent past, the cases of brain injuries have increased, and severe forms called Traumatic brain injury are about 1.5 million per year in the United States alone. Besides these, there are many other minor injuries. (Nelson, Elta, Bannister, Dzandu, Mangram & Zach 2016). Although minor, owing to the functions of the brain, there are significant risks and a need for faster diagnosis and management. According to Coles (2007), direct brain imaging after head injury will aid in preventing severe brain damage, as the action to stop further damage is taken quickly. For instance, intracranial haemorrhage can be well contained if it is discovered early. In areas like sports where life-threatening injuries occur and accident scenes where subtle brain injuries that lead to death due to misdiagnosis or ignorance, could be avoided if the brain could be scanned early on in diagnosis.
Although Near-Infrared spectroscopy (NIRS) and some EEG machines exist, NIRS is weak in imaging due to the weak nature of the rays used and the EEG machines are quite expensive. (Izzetoglu ET AL., 2015). Therefore, there is a need to develop a relatively cheap portable brain scanner that could be used out of the hospital. By so doing it could aid in preventing some deaths as well as monitoring therapy of pharmaceuticals for their efficiency.
[0051 It is an object of the current invention to provide a Portable Brain Cross scanner (PBC) that is to be used in assessing the function of the brain and its structures by combining two neuroimaging methods to give highly efficient results.
Electroencephalography (EEG) and Single-photon emission computed tomography (SP I (1,.'1), are incorporated into a single portable instrument referred to as PBC. To bring neuroirnaging health care service near to the patients for the first diagnosis of various brain pathologies fbr early intervention.
Statement of invention
[ON According to a first aspect of the invention there is provided a portable neuroimaging system comprising: an EEG device; a SPEC! device; and, a data processing and integration system, wherein the EEG device and SPECT device are simultaneously used on a patient, the output from both the EEG and SPECT devices are sent to the data processing and integration system, which process both outputs and displays the results to a user.
[007] An embodiment of the invention wherein the SPECT device comprises: at least one collimator; at least one scintillator; and, at least one photomultiplier.
[008] An embodiment of the invention wherein the SPECT device comprises: at least one gamma camera.
[9] An embodiment of the invention wherein the at least one collimator has an aperture size of approximately 0.2mrn and a septal thickness of 0.05mm.
[10] An embodiment of the invention wherein the EEG device comprises a 20 maxim-um of 10 electrodes.
[11] An embodiment of the invention wherein each electrode has an associated differential amplifier.
[012] An embodiment of the invention further comprising a power source and a power regulator, wherein the power regulator provides power to the I V, device and SPECT device from the power source at different power levels respectively.
[13] An embodiment of the invention wherein the power source is in the form of rechargeable batteries and/or an external power source.
[14] An embodiment of the invention wherein the data processing and integration system has internct access.
Brief Description of the Drawings
[15] Figure 1 depicts a schematic view of the invention, [16] Figure 2 depicts an embodiment of the invention, [17] Figure 3 depicts an embodiment of the invention.
Detailed Description
[18] The PBC scanner is a hybrid between SPECT and EEG In neuroimaghig many hybrids have been done such as SPECT/PET or MM/PET. According to an example embodiment the PBC brain scanner prototcipe will have Collimators of 0.2 mm will be used for increase resolution of the images, with septic of thickness 0.05 mm. The collimators will be made of beryllium. High voltage external power supply and high-resolution gamma camera, for the SPECT part. The EEG component in an example embodiment has a potential of 3v, a powerful filter and amplifiers, as well as 15 electrodes with an allowance of 5 more electrodes. This refers to an example embodiment only.
[019] Throughout this application the term "portable" is used. This is intended to mean that the device is not fixed in a single location for it to remain operable and instead can be moved to a desired location and minimal to zero set up is required after being moved for the device to be operable and functional.
SPECT Instruments Aperiun, [020] The area of the aperture is key in determining the sensitivity, as well as the resolution of the system. 'the areas of the aperture should be keenly considered during the construction of the equipment to ensure high resolution and sensitivity in the portable conditions. Increasing the area of the aperture leads to an increase in sensitivity as more protons are allowed to pass through, as the area is decreased, it leads to a decrease in sensitivity as the number of passing photons decreases. Conversely, for resolution of the small regions of the brain, a smaller aperture is needed to give a clear resolution of the areas emitting radiation in the brain. In this case, then image resolution increase as the area of the aperture decreases. This then follows that the construction will take into account resolution and sensitivity. The weighing of the benefits of one parameter over the other will be utilized. One of the factors must be sacrificed over the other. In the present invention, the coupling with EEG gives the ability to focus more on resolution than sensitivity. According to the nature of the study, resolution is more important, and sensitivity issues will be covered by EEG Collimators of 0.2 mm will be used for increase resolution of the images, with septic of thickness 0.05 mm. The collimators will be made of copper and beryllium glued together Gavunu Caltleta [021] The Gamma-ray camera is the one that collects the images, by detecting the gamma rays emitted by the radioligand. Since its invention in the 1950's it has been used in the detection of photons that are emitted by various radiopharmaccuticals that emit gamma rays, especially Iodine-125. The camera must have quality photo-multiplier tubes, radiation goes through the collimator and interacts first with the crystal scintillator to produce scintillation. The scintillator absorbs the gamma 5 radiation and produces visible photons. The photons emitted by radioactive substances lead to the transfer of energy to scintillator atomic electrons leading to excitation. De-excitation may also produce Ultraviolet rays and/ visible rays. Photomultiplier tubes give information about time and location of the photons through photoelectric effect. (Ryvlin, Philippon, Cinotti, Froment, Le Bars, 8,: Mauguiete, 2012). Due to this, the tubes must be -well shielded for efficient emission and transmission of photons.
[0221 In an example embodiment, three four-inch camera detectors will be used. The cameras will help in determining the depths of the areas assessed as well as 15 providing the three-dimensional images.
Poner Supply [0231 A high voltage power supply will be provided by rechargeable batteries, and 20 external power can be used in places where there is electricity Radiopharmacatlial is [0241 Since the goal of SPECT is to give information on how a given radiopharmaceutical is being distributed in the body. The radiopharmaceutical has a ligand which interacts with the tissues and a radioactive tag that is used in tracing the distribution thereof Some of the common labels used are Radioactive Iodine-125, Iodine 123, Iodine, 131, Xenon-133, thallium-201, Fluorine-18, and Technetium 99. (Ryvlin, Philippon, Cinotti, Froment, Le Bars, & Mauguiere, 2012).
10251 Radiolabelled molecular Imaging Probes (RMIP) aid in giving target molecular therapy or diagnosis. There are general rules for choosing an RMTP. An ideal RMIP has the following characteristics: IIas a high affinity for molecular targets ii) It is highly specific and has does not completely saturate given molecular targets.
Has high membrane permeability with high intracellular trapping, for longer periods to allow focusing.
iv) Rapid clearance from non-specific locations.
v) They are rapidly cleared from plasma and hence preventing their pool in the bloodstream. (Kung, Kung & Choi, 2013).
vi) Its favourable parameters to allow for multiple diagnoses.
[0261 Two radiopharmaceuticals will be used in the Portable Brain Cross scanner. Xenon-133 and Technetium, 99. Radioactive Technetium enters tumour cells preferably and doesn't enter the normal cells. Hence it will be used to in detecting brain tumours and other cerebrovascular disorders such as Huntington's disease, Parkinson's disease, stroke, dementia, and other psychiatric disorders. (Saha, MacIntyre & Cc), 2014). Radioactive xenon will be used to monitor the cerebral blood flow to indicate the metabolism of the brain and hence, its functional viability. Besides these key radiopharmaceuticals, other pharmaceuticals such as Iodine will be used depending on the situation being assessed. (RysTlin, Philippon, Cinotti, Froment, I e Bars, & Mauguiere, 2012).
EEG instruments.
Electrodes [0271 The electrodes are made of small metal discs. The small discs are either of gold, tin or stainless steel overlaid with a coating of silver chloride. Steel is cheaper than gold and tin. Additionally, stainless steel is also durable and strong and hence cost effective. The electrodes will be overlaid with silver chloride. Silver chloride is a common reference electrode in many procedures. In this case it is used to reduce polarization, which presents as a major problem. In order to facilitate creation of an interface between the subject and the electrode i.e. the ionic solution and the metallic conductor. At the application of the electrode gel, it will allow detection of the small electrical potential generated. Electrodes will be labelled according to 10/20 standard system of naming, EEG electrodes.
[0281 The electrodes are placed on specific locations in accordance with the International 10-20 system. For this case, silver-chloride electrodes will be used as they are relatively cheaper and easy to obtain. Additionally, the Silver-Silver chloride electrodes have very low impedance, are highly stable and need only low voltage for offset. The number of electrodes will be flexible as other electrodes can be inserted or removed so as to incorporate the size of the children's scalp.
Additional electrodes can be needed in cases where high resolution is needed for a given area of the brain during diagnoses. So, the number of electrodes can vary according to the prevailing circumstance. However, for the present invention, the limit of the electrodes is ten so as not to compromise portability efficiency. In order to aid the placement of the electrodes the connecting cables have differentiating colours. And arc labelled according to the area of the brain to be attached to. The head of the electrode is a smooth surface that will be easily attached to the scalp.
i'igna/ A/Ephyler [29] Unlike the heart which produces prominent waves when performing electrocardiography, the brain waves have very low amplitude, and thus, it is difficult to detect a measurable wave. The amplifier, in this case, will increase the amplitude to visible levels that can be detected and seen. The choice of an amplifier was done carefully so as to avoid the interruption with the direct current that may induce other signals. The construction of the amplifier is that it needs high input dependence with low offset. The amplification of the signal produced in terms of 101-m.
[30] Every electrode has a differential amplifier for the output of its signal. The amplifier, in this case, amplifies the electrode voltage for the active electrodes, unlike the reference electrodes. The amplifier is digitalized, and its output signal is displayed in a digital monitor.
[31] The amplifier used is bipotential as it is of high quality with high gains and efficient control. The signal consumes very low power of 3 volts and hence is easy to use in settings where electricity is not easily accessible. The Instrument has low drift frequency and has a noise-reducing device known in the art attached to it to filter any noise from the cables that can interfere with the signals. The offset voltage is about 100uV and can be varied Filter [32] The signals obtained from the brain have a frequency of about 1-40T Tz, and in some cases, it can extend to about 1001N in some functional derangement conditions. TTowever, due to connection to the scalp bone, which is connected with other bones on the body, various interferences form other parts of the body will be experienced in the signals. 'the noise from the internal organs can travel across and be recorded as a potential. (Gargiulo, Bifulco, Calvo, Cesarelli, jin & Van Schalk, 2008). Other signals will also be experienced from the electrical equipment, but they are of low frequency. So, the scanner's filter will process and eliminate any interfering wave. Incorporated in the device are three filters, one which is high pass filter, an average filter, and a low pass filter, to pre-process the obtained signal to remove any interfering signal. 'the High pass filters will come in after amplification since amplification brings in some new potential that may be recorded as a wave. For efficiency the filter comes after amplification.
Data cotzvercion and '1)nn/èniig device [33] The Arduino controller aids in the analysis of the signal. The resulting information is processed by computer software. The collection of information in the database enables easy analysis of the data. The output can be in the form of signals at some cases the computerized interface gives a hint concerning the underlying condition.
Data Processing Inteijace [34] EEG packets are linked to a software analysing the gamma camera images to provide a platform of a mixed image output that is assessed for information from both techniques. In some cases, the EEG or SPECT can be used on its own without the other. Data packets arc offered according to the hardware arrangement, and single packets are sent in recording filtering the signals and constructing three dimensions output. Various data analysis software known in thar art is added to the computer and hence provides a synchronized data output for the PBC scanner. Data classifier, filters, and collecting packets are well arranged in the data processor. The processor has an additional component whereby all the information is converted into a graphical output with high-resolution images for the SPECT side.
Power Regulation.
[0351 Power control in the device is very precise and accurate. There are no rooms for overheating. A plurality of power sinks are inserted in the electronic part. The power supply, whether from electricity or battery, is regulated before it reaches the amplifiers and the integrated circuits. Low voltage will be supplied by portable batten-es that are rechargeable for cost-effectiveness. Additionally, an AC adapter will be used in case an external mains power source is used. The PBC scanner will work with an optimum of about 3 volts. The power level going into a cathode tube of the scintillator is different to the power level going to the EEG The PCB has software known in the art to track voltage supplied into all the parts of the equipment and automatically regulates it. The voltage regulator will have many capacitors coupled to it.
The PCB [061 The PBC scanner incorporates the concepts of I d V, and SPI Cl for brain neuroimaging for determination of both functional and structural abnormalities.
[37] The model of the scanner is as shown in figure 1 with each component, i.e. EEC and SPECT working separately but converging in the Data processing and integration centre. The converging point is provided by a fast laptop computer with pre-installed data processing hardware and software. All the images are displayed and analysed on the computer. The results are recorded and stored in the computer. If the scanning indicated a clinical emergency, the data is sent to the hospital via the internet as the patient is being rushed to the hospital. This saves the time that would be taken for diagnosis and hence, a prompt action that can save a person form a further fatal progression of brain injury effects.
[38] The signal waves are assessed and recorded by the EEG equipment and the images of the various brain parts according to the emission of gamma rays are displayed. The data obtained is then used in assessing if there is any structural aberration or any functional derangement for an action to be taken in time.
[39] The portable brain scanner has combined the two techniques to provide very powerful portable neuroimagthg equipment. The SPECT component is used to give the images of the brain after injection of a radiolig,and that emits gamma rays that are detected by a gamma camera that is attached to a cathode that produces the images. In association with the scin-tillator. The SPECT component is used to assess the functioning of the brain as well as any structural abnormality resulting from brain injury. The EEG component serves to determine the activity of the brain by analysing the brain waves. The electrodes are attached to the scalp and their electrical signals amplified and recorded consequently. The recording is then interpreted. The two components are synchronized by an integrating centre that has a computer laptop which gives one combined output from the two components hence easy for analysis.
[40] Monitoring and management of many brain conditions can also be done by this portable machine efficiently.
Data I landling/Analysis in PBC Scanner.
[41] The data analysis of the EEG implements a platform known as independent component analysis alongside frequency/Time analysis with many modes of visualization. junk data can be grouped easily into individual components using this software. Since much of the data obtained is usually bulky, a data processing tool capable to deal with each individual component is considered. The data handling is majorly based on statistics. The statistical analysis component includes times and frequencies in order to avoid any drift from the result for better interpretation of the result. The electrophysiological data can be turned to smooth signal and the cortical signals can be differentiated from non-brain 11 V, signals.
The graphic user interface for the software can be integrated and any modification are allowed as plug ins are enabled.
[42] Additionally, in the data handling system integrated anatomical and physiolop,ical data (IAPD) software will be available for thtegrated analysis of the data from the EEG waves. Due to advancement in technology, the data can be automatically related and analysed to match the most likely circumstances related to the result. The analysis will provide a gateway to proper diagnosis and may open ways for the use of the equipment without aid form experts. This is an advantage because the PBC brain scanner is meant for use in areas where other machines are not available, hence the possibility to be used in remote places where there are no experts.
[43] 11 V, data contains many irrelevant details. The raw data has then to be analysed to make it in order to make it useful. Some of the data may be identified as noise or disruption and in the real sense it is not noise. In the PBC cross scanner, other sensors may be attached to scalp PEG. For instance, eye trackers. This will aid in data processing because the functional modality of the eye is regulated in the brain and the blinks have a diagnostic indication and is involved in artefact formation. The artefacts may disrupt the data obtained in EEG, apart from blinking, muscle waves or heart waves many be conducted and recorded by EEG as the electrodes are attached to the scalp bone to which other body impulses may reach. In order to deal with the artefacts, the data processing zone will have a relevant tool to exclude all the artefacts. By considering individual components by using Individual component analysis (ICA) tool, the waveforms will be considered singly and blind source separation. The individual analysis of each software will best suit the evaluation for increased accuracy. The PBC brain scanner, alongside eliminating the artefacts, it will analyse them separately to aid in the diagnosis. A software to do the integrated analysis will be included in the Data processing tool box.
[0441 Statistical parametric monitoring (SRM) will be used in analysing the SPECT component data. Tracer interpretation will be key and the 3D localization software will be used in analysis. Principal component analysis (PCA) will be key in analysis.
Change-rate map will be included in the data handling software in order to assist M determining the rate of cerebral blood flow from the gamma camera output. Univariate or multivariate analysis can be involved alongside texture analysis. Overall analysis of the data will be computer aided that is normalized for various radiotracers.
10451 Since the PBC scanner has two components, both components will be optimized for analysis and the output will be integrated in order to be indicative of a given diagnosis. The statistical analysis will be done by one software in order to aid consistence form the two components. The correction factors will be standardized based on the output form the two components. Finally, the data centre will have an allowance to include inputs from other medical databases and software that will aid in integ,rated diagnosis.
ADVANTAGES AND DISADVANTAGES OF PBC SCANNER
AdrantaAes [46] Combination of EEG and SPECT will aid in minimizing diagnostic errors.
The combination of the two will result in high accuracy of brain imaging unlike individual instruments when they are used separately. Hence the its convenience and reliability. Additionally, it will be convenient in that one component can cater for the deficiency of another during imaging, or when one fails.
The SPEC! Co anent [47] Single photon emission computed tomography (SPECT) is a superior diagnostic tool that has turned diagnostic medicine to a higher level. In comparison to other methods such as X-ray or even its counterpart Positron Emission Tomography (PET), SPELT is a relatively safe method as it employs minimal radiation and is associated with higher levels of safety. One of the factors considered before neurohnaging, is safety and this is covered well in SPECT. Other than safety, SPECT is less expensive compared to Magnetic Resonance imaging (MRI) and PET. Due to the relatively affordable cost, it is extensively used by many diagnostic facilities and hence the reason to include it in the PBC scanner. Additionally, the SPECT component on the PBC brain scanner provides for improved resolution and hence helps in making a correct diagnosis. The sensitivity of SPELT is quite high and hence good for use in detecting brain damage and any structural change in the brain.
The PEG Component [048] There is no other safe method of neuroimag,ing better than EEG. In this component, there is no input from the system to the patient, rather the equipment detects the output from the patient only. Due to high sensitivity, it offers better precision time measurements at very high resolutions of a single millisecond. The equipment works at a very high speed in great accuracy. The component is quite cheap and can be acquired by anybody who wants it. Its price cannot be compared with Mkt or PET because it is far cheaper. Finally, it is a non-invasive method as the electrodes are attached to the skull and the activity of the brain is assessed.
Hence it minimizes complications involved with invasive procedures.
DISADVANTAGES OF PBC BRAIN SCANNER
[049] The spatial resolution of EEG may present some disadvantage, but this is compensated by the SPECT component. The specificity of the exact area in the brain where some abnormal activity takes place, cannot be located precisely by EEG component, although it will detect the abnormality on the gross level. Closely adjacent areas present a problem when determining the exact part of activity.
however, these deficiencies can be compensated by SPECT component. One of the main disadvantages of SPECT component is that it has a high risk of radiation. This is because the equipment uses radioisotopes which undergo decay and release radiation. If the radiopharmaceutical and the radiation produced are not handled properly, they may lead to some effects. However, the design of the PBC scanner wIll enhance proper handling of the radiopharmaceuticals. Additionally, the EEG component will be used alone in many instances where handling of the radiopharmaceuticals may be compromised.
APPLICATIONS OF PBC SCANNF,R.
[50] PBC hybrid scanner will only be used in the medical field although it can be adapted for various uses in diverse fields. Neuroimaging-PBC brain scanner can be used in diagnosis. Some neurodegenerative conditions such as Alzheimer's disease and parkinsonism and epilepsy can be diagnosed by the machine. This is because the LEG component can detect dementia and brain structure changes which could help in diagnosis. In cases of brain damage or head injury, the combined component interface will in visualization and determination of the area of the brain that has been injures. Brain dysfunction and encephalopathy can be easily detected. Since only neurons transmit action potential, strokes can be figured out using the scanner as no impulses are recorded in the areas encountering cell death. (Iniewski, 20(39). Additionally, the signals are characteristic of the state of alertness, sleep disorders and even monitoring patients in a comatose can be easily diagnosed by the EEC component The combined methods aid in visualization of brain tumours. Brain tumours have a different metabolic rate in comparison to normal brain areas, as well their electrical conduction is different [51] Apart from neuroimaging, the PBC scanner SPECT component can be used 20 to study myocardial perfusion in the diagnosis of cardiovascular disorders such as Ischerrric heart disease. Additionally, the SPECT component can be used to diagnosis of vertebral fracture. (Halama & Henkin, 2006).
PBC Scanner Embodiment [52] The I d kI component as shown in figure 2 has a SP I (1:1. component head on which scintillator detectors, collimators and Photomultiplier tubes are attached for detection of gamma rays. The Id V] component is set some distance from the head of the SPECT from where it is attached to the SPECT component. As shown in figure 2, the information from both components is analysed in one monitor.
[053] The relative position of SP ECU and PEG component id shown in figure 2. 5 The main things in the PBC scanner prototype arc electrodes of the EEG, and SPECT detectors as shown in figure 3. The whole equipment has one display only to analyse the information from the SPEC: and EEG equipment together.
Claims (10)
- Claims 1 A neuroimaging system comprising: an EEG device; a SPECT device; and, a data processing and integration system; wherein the LEG device and SPI (1;11 device are simultaneously used to scan a patient, and the scan outputs from both the EEG and SPECT devices are sent to the data processing and integration system, which processes both scan outputs and displays the results to a user.
- 2 A neuroimaging system according to claim 1 wherein the SPECT device comprises: at least one collimator; at least one scintillator; and, at least one phommultiplier.
- 3. A neuroimaging system according to claim 1 wherein the SPECT device comprises: at least one gamma camera.
- 4. A neuroimaging system according to claim 2 wherein the at least one collimator has an aperture size of approximately 0.2mm and a septal thickness of approximately 0.05mm.
- 5. A neuroimaging system according to any preceding claim wherein the EEG device comprises a maximum of ten electrodes.
- 6. A neuroimaging system according to claim 5, wherein each electrode has a respective associated differential amplifier.
- 7 A neuroimaging system according to any preceding claim further comprising a power source and a power regulator, wherein the power regulator provides power from the power source to the LEG-device at a first power level, and to the SPELT device at a second level different from the first level.
- 8. A neuroimaging system according to claim 7 wherein the power source is in the form of rechargeable batteries and/or an external power source.
- 9. A neuroimaging system according to any preceding claim wherein the data processing and integration system has Internet access.
- 10.A neuroimaging system according to any preceding claim wherein the neuroimaging system is portable.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2004587.8A GB2593874A (en) | 2020-03-30 | 2020-03-30 | Portable brain scanner |
| GB2104145.4A GB2593817A (en) | 2020-03-30 | 2021-03-24 | Portable brain scanner |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2004587.8A GB2593874A (en) | 2020-03-30 | 2020-03-30 | Portable brain scanner |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB202004587D0 GB202004587D0 (en) | 2020-05-13 |
| GB2593874A true GB2593874A (en) | 2021-10-13 |
Family
ID=70553270
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2004587.8A Withdrawn GB2593874A (en) | 2020-03-30 | 2020-03-30 | Portable brain scanner |
| GB2104145.4A Withdrawn GB2593817A (en) | 2020-03-30 | 2021-03-24 | Portable brain scanner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2104145.4A Withdrawn GB2593817A (en) | 2020-03-30 | 2021-03-24 | Portable brain scanner |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB2593874A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120083647A1 (en) * | 2010-09-30 | 2012-04-05 | Harry Scheinin | Method for changing an individual's state of consciousness |
| US20150227702A1 (en) * | 2014-02-10 | 2015-08-13 | Picofemto LLC | Multi-factor brain analysis via medical imaging decision support systems and methods |
| US20190332900A1 (en) * | 2018-04-30 | 2019-10-31 | Elekta Ab | Modality-agnostic method for medical image representation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013102180A1 (en) * | 2011-12-30 | 2013-07-04 | Neurotrek, Inc. | Optimization of ultrasound waveform characteristics for transcranial ultrasound neuromodulation |
| WO2013152035A1 (en) * | 2012-04-02 | 2013-10-10 | Neurotrek, Inc. | Device and methods for targeting of transcranial ultrasound neuromodulation by automated transcranial doppler imaging |
| US10986992B2 (en) * | 2016-08-17 | 2021-04-27 | Massachusetts Institute Of Technology | Dynamic display system and method for customizing a controller in a display system |
| WO2019241795A1 (en) * | 2018-06-15 | 2019-12-19 | Newton Howard | Transcutaneous electrically amplified cognitive enhancement system |
-
2020
- 2020-03-30 GB GB2004587.8A patent/GB2593874A/en not_active Withdrawn
-
2021
- 2021-03-24 GB GB2104145.4A patent/GB2593817A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120083647A1 (en) * | 2010-09-30 | 2012-04-05 | Harry Scheinin | Method for changing an individual's state of consciousness |
| US20150227702A1 (en) * | 2014-02-10 | 2015-08-13 | Picofemto LLC | Multi-factor brain analysis via medical imaging decision support systems and methods |
| US20190332900A1 (en) * | 2018-04-30 | 2019-10-31 | Elekta Ab | Modality-agnostic method for medical image representation |
Non-Patent Citations (1)
| Title |
|---|
| Biocybernetics and Biomedical Engineering, Vol. 33, No. 4, 2013, Kowalczyk, M., Bajera, A., Goszczynska, H., Zalewska, E. & Krolicki, L., "Integration of EEG and SPECT data acquired from simultaneous examinations", pages 196-203 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB202104145D0 (en) | 2021-05-05 |
| GB2593817A (en) | 2021-10-06 |
| GB202004587D0 (en) | 2020-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101273919B (en) | Sequential image acquisition with updating method and system | |
| Kawano et al. | Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients | |
| US7592600B2 (en) | Diagnosis device for radiographic and nuclear medical examinations | |
| US20070223651A1 (en) | Dual modality mammography device | |
| CN109475339B (en) | Systems and methods for monitoring metabolic activity and detectors for detecting photons | |
| US8155408B2 (en) | Standardized normal database having anatomical phase information | |
| US20120093383A1 (en) | Sequential image acquisition method | |
| JP4162242B2 (en) | Diagnostic imaging support system | |
| JP2008206556A (en) | Medical image processing system | |
| JP4685078B2 (en) | Diagnostic imaging support system | |
| Ma et al. | Exploratory study of a multifrequency EIT-based method for detecting intracranial abnormalities | |
| Cox et al. | High-resolution three-dimensional microelectrode brain mapping using stereo microfocal X-ray imaging | |
| GB2593874A (en) | Portable brain scanner | |
| Zhou et al. | Localizing epileptic foci before surgery in patients with MRI-negative refractory epilepsy using statistical parameter mapping and three-dimensional stereotactic surface projection based on 18F-FDG PET | |
| JP5107538B2 (en) | Diagnostic imaging support system and method | |
| Buch et al. | Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization | |
| JP4775189B2 (en) | Medical diagnostic equipment | |
| JP5140810B2 (en) | Tomographic image overlay display method and computer program for displaying tomographic images superimposed | |
| US7030384B2 (en) | Adaptive opto-emission imaging device and method thereof | |
| Sule et al. | Diagnostic Imaging Techniques: Current Trends and Challenges | |
| Chen | Jiaqi Liu, Yunliang Zang, Yang Li, and | |
| RU163437U1 (en) | COMBINED DEVICE FOR DIAGNOSIS OF BREAST DISEASES | |
| US20240366176A1 (en) | Systems and methods for injection dose calibration in pet imaging | |
| Bisello et al. | Advances in Hybrid Imaging: PET/CT | |
| Alemdar et al. | Embedded Systems in Developing Imaging Devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |